Nippon India Pharma Fund - Direct - Growth

Equity Schemes by Nippon Life India Asset Management Limited

3Y Returns (CAGR)
18.93%
Expense Ratio
0.93%

as of 01/06/2026

AUM
₹2,251.45 Cr

Qtr End: Jun 26

NAV
₹646.864

as of 02/09/2026

Historical Performance
Investment growth and SIP performance over time.
Performance Metrics
Returns, CAGR, and Volatility.
Period
Returns
CAGR
Volatility
3M7.96%35.82%9.61%
6M13.07%27.85%12.71%
1Y13.28%13.28%11.98%
3Y68.23%18.93%13.10%
5Y95.95%14.40%13.07%
Scheme Details
Launch Date
10/05/2004
Fund Age
22.3 years
Minimum Investment
₹5,000
Fund House
Nippon India Mutual Fund
Category
Equity Scheme
Sub-category
Sectoral/ Thematic (Equity Scheme)

Frequently Asked Questions